MRI-Based Evaluation of the Vaginal Cuff in Brachytherapy Planning: Are We Missing the Target?
暂无分享,去创建一个
Shruti Jolly | Yue Cao | James M Balter | Joann I Prisciandaro | S. Jolly | J. Balter | Yue Cao | C. Chapman | K. Maturen | J. Prisciandaro | K. McLean | Christina Hunter Chapman | Katherine E Maturen | Karen McLean
[1] H. Kauczor,et al. Imaging of female pelvic malignancies regarding MRI, CT, and PET/CT , 2011, Strahlentherapie und Onkologie.
[2] S. Jolly,et al. Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer. , 2005, Gynecologic oncology.
[3] C. Sirlin,et al. MRI of the female pelvis using vaginal gel. , 2005, AJR. American journal of roentgenology.
[4] Rémi,et al. Endometrium FIFTEEN-YEAR RADIOTHERAPY OUTCOMES OF THE RANDOMIZED PORTEC-1 TRIAL FOR ENDOMETRIAL CARCINOMA , 2011 .
[5] H. Kauczor,et al. Imaging of female pelvic malignancies regarding MRI, CT, and PET/CT , 2011, Strahlentherapie und Onkologie.
[6] M. Siedhoff,et al. Decreased incidence of vaginal cuff dehiscence after laparoscopic closure with bidirectional barbed suture. , 2011, Journal of minimally invasive gynecology.
[7] Antonio Farina,et al. Vaginal cuff dehiscence after hysterectomy: a multicenter retrospective study. , 2011, European journal of obstetrics, gynecology, and reproductive biology.
[8] P. Grigsby,et al. Dosimetric effects of air pockets around high-dose rate brachytherapy vaginal cylinders. , 2010, International journal of radiation oncology, biology, physics.
[9] H. Putter,et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial , 2010, The Lancet.
[10] S. Davidson,et al. Magnetic resonance imaging of primary vaginal carcinoma. , 2007, Clinical radiology.
[11] J. Rownd,et al. American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy. , 2012, Brachytherapy.
[12] M. Maiman,et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. , 2004, Gynecologic oncology.
[13] Harry Easton,et al. Customized vaginal vault brachytherapy with computed tomography imaging-derived applicator prototyping. , 2015, Brachytherapy.
[14] J. Lee,et al. MR appearance of the normal and abnormal vagina after hysterectomy. , 1992, AJR. American journal of roentgenology.
[15] J. Adam M. Cunha,et al. Evaluation of PC-ISO for customized, 3D printed, gynecologic 192Ir HDR brachytherapy applicators. , 2015, Journal of applied clinical medical physics.
[16] H. Putter,et al. Long-term impact of endometrial cancer diagnosis and treatment on health-related quality of life and cancer survivorship , 2022 .
[17] Hye-Chun Hur,et al. Incidence and patient characteristics of vaginal cuff dehiscence after different modes of hysterectomies. , 2007, Journal of minimally invasive gynecology.
[18] Christian Kirisits,et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[19] S. Jolly,et al. Single or multi-channel vaginal cuff high-dose-rate brachytherapy: Is replanning necessary prior to each fraction? , 2014, Practical radiation oncology.
[20] H. Putter,et al. Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data. , 2012, European journal of cancer.
[21] Ken Goldberg,et al. Evaluation of PC‐ISO for customized, 3D printed, gynecologic 192Ir HDR brachytherapy applicators , 2015, Journal of applied clinical medical physics.
[22] A. Viswanathan,et al. A novel low dose fractionation regimen for adjuvant vaginal brachytherapy in early stage endometrioid endometrial cancer. , 2012, Gynecologic oncology.
[23] B. Sorbe,et al. Intravaginal high-dose-rate brachytherapy for stage I endometrial cancer: a randomized study of two dose-per-fraction levels. , 2005, International journal of radiation oncology, biology, physics.